These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 108675)

  • 1. Isolation and characterization of purine-nucleoside phosphorylase-deficient T-lymphoma cells and secondary mutants with altered ribonucleotide reductase: genetic model for immunodeficiency disease.
    Ullman B; Gudas LJ; Clift SM; Martin DW
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1074-8. PubMed ID: 108675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of 2'-deoxyguanosine toxicity in mouse T-lymphoma cells with purine nucleoside phosphorylase deficiency and resistance to inhibition of ribonucleotide reductase by dGTP.
    Duan DS; Nagashima T; Hoshino T; Waldman F; Pawlak K; Sadee W
    Biochem J; 1990 Jun; 268(3):725-31. PubMed ID: 2114100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxyguanosine toxicity in a mouse T lymphoma: relationship to purine nucleoside phosphorylase-associated immune dysfunction.
    Gudas LJ; Ullman B; Cohen A; Martin DW
    Cell; 1978 Jul; 14(3):531-8. PubMed ID: 99243
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for genetically independent allosteric regulatory domains of the protein M1 subunit of mouse ribonucleotide reductase.
    Eriksson S; Gudas LJ; Clift SM; Caras IW; Ullman B; Martin DW
    J Biol Chem; 1981 Oct; 256(19):10193-7. PubMed ID: 7024267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of purine-nucleoside phosphorylase deficiency.
    Albert D; Bluestein HG; Willis RC; Nette K; Seegmiller JE
    Cell Immunol; 1984 Jul; 86(2):501-9. PubMed ID: 6428752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of normal and mutant protein M1 subunits of deoxyGTP-resistant ribonucleotide reductase from mutant mouse lymphoma cells.
    Ullman B; Gudas LJ; Caras IW; Eriksson S; Weinberg GL; Wormsted MA; Martin DW
    J Biol Chem; 1981 Oct; 256(19):10189-92. PubMed ID: 7024266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency.
    Cohen A; Gudas LJ; Ammann AJ; Staal GE; Martin DW
    J Clin Invest; 1978 May; 61(5):1405-9. PubMed ID: 96138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
    Albert DA; Gudas LJ
    J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).
    Carson DA; Kaye J; Seegmiller JE
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5677-81. PubMed ID: 202960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxyribonucleoside triphosphate metabolism and the mammalian cell cycle. Effects of hydroxyurea on mutant and wild-type mouse S49 T-lymphoma cells.
    Eriksson S; Skog S; Tribukait B; Wallström B
    Exp Cell Res; 1987 Jan; 168(1):79-88. PubMed ID: 3096753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
    Wilson JM; Mitchell BS; Daddona PE; Kelley WN
    J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism of deoxyguanosine and guanosine in human B and T lymphoblasts. A role for deoxyguanosine kinase activity in the selective T-cell defect associated with purine nucleoside phosphorylase deficiency.
    Osborne WR; Scott CR
    Biochem J; 1983 Sep; 214(3):711-8. PubMed ID: 6312962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of purine nucleoside phosphorylase deficiency by retroviral-mediated gene transfer in mouse S49 T cell lymphoma: a model for gene therapy of T cell immunodeficiency.
    Foresman MD; Nelson DM; McIvor RS
    Hum Gene Ther; 1992 Dec; 3(6):625-31. PubMed ID: 1482702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary loss of deoxyguanosine kinase activity in purine nucleoside phosphorylase deficient mice.
    Snyder FF; Jenuth JP; Dilay JE; Fung E; Lightfoot T; Mably ER
    Biochim Biophys Acta; 1994 Oct; 1227(1-2):33-40. PubMed ID: 7918681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.
    Ullman B; Cohen A; Martin DW
    Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
    Carson DA; Kaye J
    Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy-GTP in conditions simulating purine nucleoside phosphorylase deficiency.
    Fairbanks LD; Taddeo A; Duley JA; Simmonds HA
    J Immunol; 1990 Jan; 144(2):485-91. PubMed ID: 2104895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of deoxyguanosine by B and T lymphocytes: evidence against selective trapping of deoxyguanosine by T lymphocytes in purine nucleoside phosphorylase deficiency.
    North ME; Newton CA; Webster AD
    Clin Exp Immunol; 1980 Dec; 42(3):523-9. PubMed ID: 6783354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purine nucleoside phosphorylase deficiency associated with a fatal lymphoproliferative disorder.
    Watson AR; Evans DI; Marsden HB; Miller V; Rogers PA
    Arch Dis Child; 1981 Jul; 56(7):563-5. PubMed ID: 6791594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.